Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nutriband Inc. - Common Stock (NQ:NTRB)

5.745 -0.355 (-5.82%)
Streaming Delayed Price Updated: 2:47 PM EDT, Sep 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Nutriband Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) CEO to Attend Inaugural Nasdaq LaB Biotech Summit
Via Investor Brand Network
News headline image
Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit
From Nutriband Inc.
Via GlobeNewswire
InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Advances Trademark Protection for Abuse-Deterrent Fentanyl Patch
Via Investor Brand Network
Topics Intellectual Property
News headline image
Nutriband Receives USPTO Notice of Publication of Commercial Brand Name Trademarks for Its Abuse Deterrent Fentanyl Patch
From Nutriband Inc.
Via GlobeNewswire
MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) CEO to Present at 2026 Georgia Life Sciences Summit
Via Investor Brand Network
News headline image
Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight
From Nutriband Inc.
Via GlobeNewswire
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Subsidiary Active Intelligence to Showcase Wellness Products at ECRM Conference
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference
From Nutriband Inc.
Via GlobeNewswire
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) CEO Highlights AVERSA Technology on Jack Neel Podcast
Via Investor Brand Network
Topics Intellectual Property
News headline image
Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast
From Nutriband Inc.
Via GlobeNewswire
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Selects Global Brand Name Candidate for AVERSA(TM) Fentanyl Patch
Via Investor Brand Network
News headline image
Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch
From Nutriband Inc.
Via GlobeNewswire
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Secures Costa Rica Approval for Kinesiology Tape Line
Via Investor Brand Network
News headline image
Nutriband AI Kinesiology Tapes approved for Distribution and Sale in Costa Rica
The Company recently announced an exclusive distribution agreement with Innomedica CCB S.A. for its Kinesiology Line, AVERSA products and Mosquito repellent patches 
From Nutriband Inc.
Via GlobeNewswire
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Signs Exclusive Costa Rica Distribution Deal for AVERSA Fentanyl and Sports Tape Products
Via Investor Brand Network
Topics Intellectual Property
News headline image
Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica
From Nutriband Inc.
Via GlobeNewswire
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) Highlights Board Appointments and AVERSA Fentanyl Milestones From Annual Meeting
Via Investor Brand Network
Topics Intellectual Property
News headline image
Nutriband Inc. provides summary of Annual Shareholder Meeting Key Discussion Points
From Nutriband Inc.
Via GlobeNewswire
NetworkNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) CEO Issues Shareholder Letter Highlighting 2025 Milestones and 2026 Outlook
Via Investor Brand Network
Topics Intellectual Property
News headline image
Nutriband CEO Publishes Letter to Shareholders
From Nutriband Inc.
Via GlobeNewswire
InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Sells 90% Stake in Pocono Pharmaceutical for $5 Million
Via Investor Brand Network
News headline image
Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio
From Nutriband Inc.
Via GlobeNewswire
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Signs LOI to Explore Quantum-AI Technology Collaboration
Via Investor Brand Network
Topics Artificial Intelligence
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Responds to Fentanyl WMD Executive Order, Highlights AVERSA(TM) FENTANYL Development
Via Investor Brand Network
Topics Government
News headline image
Nutriband Inc. Signs Letter of Intent with Qvanta Group of Companies to Explore Advanced Technology Solutions for Abuse-Deterrent Pharmaceutical Innovation Strategic Exploration
The LOI Aligns with Federal Priorities on Fentanyl Crisis, Artificial Intelligence, and Quantum Technology 
From Nutriband Inc.
Via GlobeNewswire
News headline image
Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction
From Nutriband Inc.
Via GlobeNewswire
NetworkNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Announces Chairman Presentation at NobleCon21
Via Investor Brand Network
News headline image
REPEAT — Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch
From Nutriband Inc.
Via GlobeNewswire
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Receives FDA Meeting Feedback Advancing AVERSA(TM) Fentanyl Toward 505(b)(2) NDA Submission
Via Investor Brand Network
Nutriband Inc. (NASDAQ:NTRB) Targets the Opioid Safety Gap in a Multi-Billion-Dollar Market
Via AB Newswire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.